After years of poor performing management and wasting $millions of shareholders money, I suspect AHZ is on the cusp of fulfilling some of it's delayed potential. There is a constant uplift in ADAPT sales and with the imminent release of their new product, I suspect that the market will see the "true" potential of this stock, without constantly looking at the past. I too agree with many others, that WP has made statements, but not delivered on time and budget, however biotech is a tough business placed in a tough market and there now seems some positives coming from the group. Time will tell of course and it has been a long road, a long painful road. I and I am sure, many other long term holders who were sitting on "hold" are now thinking of hitting the "buy" button, cautiously, to average down and take advantage of what looks like, a bright future. Lets face it, on a world scale, AHZ is outrageously cheap, even considering the past stumbles, I am thinking the "worm is turning"! My opinion only, not advice! GLTA
- Forums
- ASX - By Stock
- AHZ Revisited
After years of poor performing management and wasting $millions...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$9.90 |
Change
-1.000(9.17%) |
Mkt cap ! $209.2M |
Open | High | Low | Value | Volume |
$10.50 | $10.79 | $9.30 | $1.212M | 122.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 153 | $9.82 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.90 | 2 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 283 | 9.820 |
3 | 778 | 9.810 |
2 | 1184 | 9.800 |
1 | 507 | 9.790 |
3 | 3630 | 9.700 |
Price($) | Vol. | No. |
---|---|---|
10.170 | 508 | 1 |
10.180 | 130 | 1 |
10.200 | 1000 | 1 |
10.300 | 1000 | 1 |
10.450 | 357 | 1 |
Last trade - 14.27pm 06/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |